Lgd4033 10mgx30tabs
$40.00
LGD-4033 was developed by Ligand Pharmaceuticals and is currently being investigated in clinical trials by Viking Therapeutics as a potential treatment for conditions involving muscle wasting and bone loss, such as those associated with hip fracture recovery, osteoporosis, and cancer cachexia.